Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (231-240 of 339) with videos related to

Pageof 34
Sort By:
Hemasphere|September 3, 2021
The EHA Research Roadmap: Malignant Myeloid DiseasesHartmut Döhner, Luca Malcovati, Gert J Ossenkoppele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study GroupMichael Lübbert, Stefan Suciu, Liliana Baila, et al.
Blood Cancer Journal|January 6, 2026
Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasmsRobert Meyer, Maria Jimena Rodriguez, Madeline Caduc, et al.
Blood|November 19, 2011
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesSabine Kayser, Manuela Zucknick, Konstanze Döhner, et al.
Genes, Chromosomes & Cancer|April 18, 2019
Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromesChristina Ganster, Catharina Müller-Thomas, Claudia Haferlach, et al.
Redox Biology|July 29, 2025
Divergent roles of red cell arginase in humans and mice: RBC Arg1 KO mice show preserved systemic l-arginine bioavailability and infarct size in vivoSophia K Heuser, Junjie Li, Zhixin Li, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
British Journal of Haematology|November 6, 2022
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registryKrzysztof Mądry, Karol Lis, Pierre Fenaux, et al.
Pageof 34

Showing results (231-240 of 339) with videos related to

Sort By:
Pageof 34
Hemasphere|September 3, 2021
The EHA Research Roadmap: Malignant Myeloid DiseasesHartmut Döhner, Luca Malcovati, Gert J Ossenkoppele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study GroupMichael Lübbert, Stefan Suciu, Liliana Baila, et al.
Blood Cancer Journal|January 6, 2026
Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasmsRobert Meyer, Maria Jimena Rodriguez, Madeline Caduc, et al.
Blood|November 19, 2011
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesSabine Kayser, Manuela Zucknick, Konstanze Döhner, et al.
Genes, Chromosomes & Cancer|April 18, 2019
Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromesChristina Ganster, Catharina Müller-Thomas, Claudia Haferlach, et al.
Redox Biology|July 29, 2025
Divergent roles of red cell arginase in humans and mice: RBC Arg1 KO mice show preserved systemic l-arginine bioavailability and infarct size in vivoSophia K Heuser, Junjie Li, Zhixin Li, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
British Journal of Haematology|November 6, 2022
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registryKrzysztof Mądry, Karol Lis, Pierre Fenaux, et al.
Pageof 34